Immunitybio sec filings
Witryna15 lut 2024 · More details about these and other risks that may impact ImmunityBio’s business are described under the heading "Risk Factors" in the Company’s Form 10-K filed with the U.S. Securities and ... WitrynaSEC Filings Business Wire ImmunityBio to Present ‘Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15R⍺Fc ...
Immunitybio sec filings
Did you know?
Witryna13 kwi 2024 · ImmunityBio currently has a consensus price target of $9.00, indicating a potential upside of 488.24%. Given ImmunityBio’s higher probable upside, analysts plainly believe ImmunityBio is more favorable than BiondVax Pharmaceuticals. Summary. ImmunityBio beats BiondVax Pharmaceuticals on 6 of the 10 factors … WitrynaLiczba wierszy: 11 · 1 mar 2024 · SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2024 2024 2024 2024 2024 2024 2024 2016 2015 …
WitrynaSEC Filings Group. Filing year. Items per page. Filing date Form Description View; Apr 06, 2024: 8-K: Report of unscheduled material events or corporate event ... Securities offered to employees pursuant to employee benefit plans. 0001193125-23-066286.pdf. 0001193125-23-066286.rtf. 0001193125-23-066286.xls. View HTML: Feb 14, 2024: Witryna15 lut 2024 · Item 1.01 Entry into a Material Definitive Agreement. Registered Direct Offering. On February 15, 2024, ImmunityBio, Inc. (the "Company") entered into a stock purchase agreement (the "SPA") with certain institutional investors (the "Investors") for the purchase and sale of 14,072,615 shares of the Company's common stock, par …
Witryna11 kwi 2024 · Various other factors are detailed from time to time in Axim’s SEC reports and filings, including our Annual Report on Form 10-K filed on April 15, 2024, and other reports we file with the SEC, which are available at www.sec.gov. Axim Biotechnologies, Inc., undertakes no obligation to update publicly any forward-looking statements to … Witryna5 cze 2024 · Other risks and uncertainties include those identified under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 as filed with the Securities and Exchange Commission (SEC) on March 13, 2024 and in any subsequent filings with the SEC.
Witryna17 lis 2024 · More details about these and other risks that may impact ImmunityBio’s business are described under the heading "Risk Factors" in the Company’s Form 10-K filed with the U.S. Securities and ...
crystallomancy definitionWitryna13 kwi 2024 · Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis. crystallomorphismWitryna12 gru 2024 · More details about these and other risks that may impact ImmunityBio’s business are described under the heading "Risk Factors" in the Company’s Form 10 … crystal lollyWitryna31 mar 2024 · SEC Filings. Analyst Coverage. Investor Faq. Corporate Governance. Subscribe for updates from inovio. Register to receive email alerts for INOVIO press releases Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, … dw that\u0027sWitryna8 mar 2024 · March 08, 2024 04:30 PM Eastern Standard Time. EL SEGUNDO, Calif.-- ( BUSINESS WIRE )-- NantKwest, Inc. ( NASDAQ: NK ), a clinical-stage, natural killer cell-based therapeutics company, today ... crystallo lighting pendantWitrynaCULVER CITY, Calif. & EL SEGUNDO, Calif., December 21, 2024 — ImmunityBio, a privately-held immunotherapy company, and NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced they have entered into an agreement to merge in a stock-for-stock transaction. The combination … crystallo meaningWitrynaCellular Biomedicine Group, Inc. - SEC Filings - Registrant - CIK 1378624 - SEC crystallology